Kenyans.co.ke

Kenya Receives First 21,000 Doses of Lenacapavir Injectable HIV PrEP

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.
KahawaTungu

Kenya rolls out long-acting Injectable HIV prevention drug Lenacapavir

Kenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, ...
The Standard

Kenya receives first batch of 21,000 HIV prevention doses

Kenya has received 21,000 starter doses of the HIV prevention injection Lenacapavir, marking a major milestone in the country’s efforts to curb new infections, particularly among young people.

Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options

Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention ...

"Old men have no business dating teen students,’ says Nomagugu Simelane as province expands HIV prevention drive

KZN Health MEC Nomagugu Simelane warns students about the dangers of inter-generational transactional relationships, urging them to focus on education and health over material temptations.